Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy

Journal of Clinical Microbiology

Volumn 41, Issue 7, 2003, Pages 3212-3220

  Veillon, Pascal ^a   Payan, Christopher ^d   Picchio, Gastón ^b   Maniez Montreuil, Michèle ^b   Guntz, Philippe ^c   Lunel, Françoise ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c Etab Francais du Sang Alsace   (France)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; INTERFERON; RIBAVIRIN; VIRUS RNA;

AMPLICOR MONITOR ASSAY; ANTIGEN DETECTION; ARTICLE; BLOOD DONOR; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DEVICE; DRUG EFFECT; EVALUATION; FOLLOW UP; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MONITOR; PATIENT MONITORING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE ASSAY; RELAPSE; REPRODUCIBILITY; RNA ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME; VIREMIA; VIRUS LOAD;

ANTIVIRAL AGENTS; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; DRUG THERAPY, COMBINATION; HEPACIVIRUS; HEPATITIS C ANTIGENS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOENZYME TECHNIQUES; INTERFERONS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RIBAVIRIN; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL CORE PROTEINS; VIRAL LOAD; VIREMIA;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0037492890     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.7.3212-3220.2003     Document Type: Article

References (30)

1. Alter, H. J., R. Sanchez-Pescador, M. S. Urdea, J. C. Wilber, R. J. Lagier, A. M. Di Bisceglie, J. W. Shih, and P. D. Neuwald. 1995. Evaluation of branched-DNA signal amplification for the detection of hepatitis C virus RNA. J. Viral Hepatitis 2:121-132.
2. Ayoagi, K., C. Ohue, K. Iida, T. Kimura, E. Tanaka, K. Kiyosawa, and S. Yagi. 1999. Development of a single and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J. Clin. Microbiol. 37:1802-1808.
3. Bland, J. M., and D. G. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet i:307-310.
4. Blatt, L. M., M. G. Mutchnick, M. J. Tong, F. M. Klion, E. Lebovics, B. Freilich, N. Bach, C. Smith, J. Herrera, H. Tobias, A. Conrad, P. Schmid, and J. G. McHutchinson. 2000. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J. Viral Hepatitis 7:196-202.
5. Bouvier-Alias, M., K. Patel, H. Dahari, S. Beaucourt, P. Larderie, L. Blatt, C. Hezode, G. Picchio, D. Dhumeaux, A. U. Neumann, J. G. McHutchison, and J. M. Pawlotsky. 2002. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology 36:211-218.
6. Chemello, L., L. Cavaletto, F. Noventa, P. Bonetti, C. Casarin, E. Bernardinello, P. Pontisso, C. Donada, P. Casarin, F. Belussi, M. Frezza, and A. Alberti. 1995. Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon alfa. J. Viral Hepatitis 2:91-96.
7. Chen, Z., and K. E. Weck. 2002. Hepatitis C virus genotyping: interrogation of the 5′ untranslated region cannot accurately distinguish genotypes 1a and 1b. J. Clin. Microbiol. 40:3127-3134.
8. Choo, Q. L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:2451-2455.
9. Gretch, D. R., L. Corey, J. Wilson, C. de la Rosa, R. Wilson, R. Carithers, Jr., M. Bush, J. Hart, M. Sayers, and J. Han. 1994. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J. Infect. Dis. 169:1219-1225.
10. Gretch, D. R., C. de la Rosa, L. Corey, and R. L. Carithers. 1996. Assessment of hepatitis C viremia using molecular amplification technologies. Viral Hepatitis Rev. 2:85-96.
11. Hagiwara, H., N. Hayashi, E. Mita, T. Takehara, A. Kasahara, H. Fusamoto, and T. Kamada. 1993. Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy. Gastroenterology 104:877-883.
12. Hagiwara, H., N. Hayashi, E. Mita, T. Takehara, A. Kasahara, H. Fusamoto, and T. Kamada. 1993. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology 17:545-550.
13. Hino, K., S. Sainokami, K. Shimoda, S. Iiono, Y. Wang, H. Okamoto, and Y. Miyakawa. 1994. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J. Med. Virol. 42: 299-305.
14. Hollingsworth, R., P. Sillekens, P. Van Deursen, K. R. Neal, W. L. Irving, et al. 1996. Serum HCV RNA level assessed by quantitative NASBA: stability of viral load over time, and lack of correlation with liver disease. J. Hepatol. 25:301-306.
15. Kato, N., O. Yokosuka, K. Hosoda, Y. Ito, M. Ohto, and M. Omata. 1993. Quantitation of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced disease. Hepatology 18:16-20.
16. Kievits, T., B. Van Gemen, S. Van Strijp, R. Schukkink, M. Dircks, H. Adriaanse, L. Malek, R. Sooknanan, and P. Lens. 1991. NASBA™ isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J. Virol. Methods 35:273-286.
17. Kobayashi, Y., S. Watanabe, M. Konishi, M. Yokoi, R. Kakahashi, M. Kaito, M. Kondo, Y. Hayashi, T. Jomori, and S. Suzuki. 1993. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon beta. Hepatology 18:1319-1325.
18. Lau, J. Y., G. L. Davis, J. Kniffen, K. P. Quian, M. S. Urdea, C. Chan, M. Mizokami, P. D. Neuwald, and J. C. Wilber. 1993. Significance of serum hepatitis C virus RNA levels in chronic hepatitis. Lancet 341:1501-1504.
19. Lunel, F., M. Mariotti, P. Cresta, I. De La Croix, J. M. Huraux, and J. J. Lefrère. 1995. Comparative study of conventional and novel strategies for the detection of hepatitis C virus RNA in serum: Amplicor, branched-DNA, NASBA and in-house PCR. J. Virol. Methods 54:159-171.
20. Lunel, F., P. Cresta, D. Vitour, C. Payan, B. Dumont, L. Frangeul, D. Reboul, C. Brault, J. C. Piette, and J. M. Huraux. 1999. Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA and monitor assays. Hepatology 29:528-535.
21. Martinot-Peignoux, M., P. Marcellin, M. Pouteau, C. Castelnau, N. Boyer, M. Poliquin, C. Degott, I. Descombes, V. Le Breton, V. Milotova, J. P. Benhamou, and S. Erlinger. 1995. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 22:1050-1056.
22. Naito, M., N. Hayashi, H. Hagiwara, K. Katayama, A. Kasahara, H. Fusamoto, M. Kato, M. Masuzawa, and T. Kamada. 1994. Serial quantitative analysis of serum hepatitis C virus RNA level in patients with acute and chronic hepatitis C. J. Hepatol. 20:755-759.
23. Navas, S., and V. Carreno. 1995. Semiquantitation by Amplicor assay of hepatitis C virus genome during therapy. J. Hepatol. 22(Suppl.1): 115-117.
24. Poynard, T., J. McHutchinson, Z. Goodman, M. H. Ling, H. J. Albrecht, et al.. 2000. Is an "A La Carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? Hepatology 31:211-218.
25. Stuyver, L., R. Rossau, A. Wyseru, M. Duhamel, B. Vanderborght, H. Van Heuversmyn, and G. Maartens. 1993. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J. Gen. Virol. 74:1093-1102.
26. Tanaka, E., C. Ohue, K. Ayoagi, K. Yamaguchi, S. Yagi, K. Kiyosawa, and H. J. Alter. 2000. Evaluation of a new immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology 32:388-393.
27. Toyoda, H., S. Nakano, T. Kumada, I. Takeda, K. Sugiyama, T. Osada, S. Kiriyama, E. Orito, and M. Mizokami. 1996. Comparison of serum hepatitis C virus RNA concentration by branched-DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon alpha therapy in chronic hepatitis C patients. J. Med. Virol. 48:354-359.
28. Urdea, M. S. 1993. Synthesis and characterisation of branched DNA (bDNA) for the direct and quantitative detection of CMV, HBV, HCV and HIV. Clin. Chem. 39:725-726.
29. Wolfe, L., S. Tamatsukuri, C. Sayada, and J. C. Ryff. 1994. Detection of HCV RNA in serum using a single-tube enzyme PCR in combination with a colorimetric microwell assay, p. 83-94. In Groupe Français d'Etude Moléculaire des Hépatites (GEMHEP) (ed.), Hepatitis V virus: new diagnostic tools. John Libbey Eurotext, Paris, France.
30. Young, K. K. Y., R. M. Resnick, and T. W. Myers. 1993. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J. Clin. Microbiol. 31:882-886.